Business
BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
Enabling Bio-Techne's gold-standard RNAscope ISH technology with Imaging Mass Cytometry detection to accelerate multiomic interrogation of health and disease.
About this update from Bio-techne Corp
[{"type":"text","content":"Enabling Bio-Techne's gold-standard RNAscope ISH technology with Imaging Mass Cytometry detection to accelerate multiomic interrogation of health and disease.\nMINNEAPOLIS, May 16, 2023 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ in situ hybridization (ISH) portfolio with the release of a RNAscope multiomic workflow for the Standard BioTools Hyperion™ Imaging System.\n\"Multiomic spatial imaging using the Hyperion Imaging System has the potential to guide the development of tissue architectural maps of health and disease in unprecedented detail and comprehensiveness,\" said Daniel Schulz, Senior Research Associate at the University of Zurich. \"The ability to link transcript, protein, and signaling networks in tissues with spatial resolution will enable assessment of drug efficacy, discovery of novel routes for intervention, and identification of informative biomarkers, and thus has the potential to become a pillar for precision medicine approaches in the future.\"\nRNAscope is the gold-standard for in situ hybridization, trusted by researchers around the globe, with a rapidly growing list of over 8,000 peer reviewed publications. With over 45,000 catalog probes available and fast, expert custom probe design capabilities, researchers have the flexibility to interrogate their genes of interest across a wide array of tissues at industry leading specificity and single-molecule sensitivity to address a variety of diseases.\nThe new RNAscope HiPlex12 Flex Kit enables visualization of highly multiplexed RNA biomarkers using the Hyperion XTi or earlier models of the Hyperion Imaging System. This system enables simultaneous detection and accurate quantification of 40-plus biomarkers from any tissue sample in a single imaging step using Imaging Mass Cytometry™ (IMC™). Providing a simple and easy method to incorporate prelabelled and user-conjugated Maxpar Antibodies from Standard BioTools during sample preparation, the new multiomic workflow will enable researchers to illuminate changes in cell phenotypes and function across a wide range of diseases using standard formalin-fixed paraffin-embedded (FFPE) tissue pathology s...